https://orcid.org/0000-0003-3998-6551
References
- Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005;72:647–652.
- Mobasher P, Zamanian A. Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart. Adv Biomed Res. 2014;3:107.
- Human papilloma virus infection. In: Wolff K, Johnson RA, editor. Fitzpatrick’s color atlas & synopsis of clinical dermatology. 8th ed. New York (NY): McGraw-Hill Education; 2017. p. 656–665.
- Rezai MS, Ghasempouri H, Asqary Marzidareh O, et al. Intralesional Injection of the measles-mumps-rubella vaccine into resistant palmoplantar warts: a randomized controlled trial. Iran J Med Sci. 2019;44:10–17.
- Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts. Cochrane Database Syst Rev. 2003. Article Number: CD001781.
- Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012. Article Number: CD001781.
- Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17:441–448.
- Leeyaphan C, Tantrapornpong P, Ungprasert P. The efficacy of diphencyprone immunotherapy for the treatment of cutaneous warts: a systematic review and meta-analysis. J Dermatolog Treat. 2019.
- Khozeimeh F, Jabbari Azad F, Mahboubi Oskouei Y, et al. Intralesional immunotherapy compared to cryotherapy in the treatment of warts. Int J Dermatol. 2017;56:474–478.
- Majid I, Imran S. Immunotherapy with intralesional Candida albicansantigen in resistant or recurrent warts: a study. Indian J Dermatol. 2013;58:360.
- Milante RR, Venida‐Tablizo A, King‐Ismael D. Efficacy and safety of single versus multiple intralesional immunotherapy with purified protein derivative (PPD) in the treatment of multiple verruca vulgaris. Int J Dermatol. 2019;58:1477–1482.
- Chandra S, Sil A, Datta A, et al. A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with Mycobacterium w vaccine in the treatment of multiple viral warts. Indian J Dermatol Venereol Leprol. 2019;85:355.
- Vlahovic TC, Spadone S, Dunn SP, et al. Candida albicans Immunotherapy for Verrucae Plantaris. J Am Podiatr Med Assoc. 2015;105:395–400.
- Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatology Venereol. 2010;24:1166–1170.
- Agrawal C, Vyas K, Mittal A.A Randomized double BlindControlled Study Comparing the Efficacy of Intralesional MMR Vaccine with Normal Saline in the Treatment of Cutaneous Warts. Indian Dermatol Online J. 2018;9(6):389
- Awal G, Kaur S.Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial. J Clin Aesthet Dermatol. 2018;11(5):15
- Chauhan PS, Mahajan VK, Mehta KS, et al. The efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults. Indian Dermatol Online J. 2019;10:19–26.